使用肥胖相关装置进行临床试验设计的考虑

Herbert Lerner, Martha W. Betz
{"title":"使用肥胖相关装置进行临床试验设计的考虑","authors":"Herbert Lerner, Martha W. Betz","doi":"10.3109/10601333.2015.983647","DOIUrl":null,"url":null,"abstract":"Abstract Diet and exercise as a first line therapy do not appear to adequately address the epidemic of obesity seen worldwide. In the US there have only been two devices legally marketed in the last 10 years intended to treat obesity, with many more under clinical investigation. New drugs have recently been approved and, although they appear to provide some benefit, the use of these is associated with many side-effects and with an uncertain sustained weight loss. Using the benefit–risk paradigm as a basis for future study design, this editorial discusses the significant issues associated with the clinical trials intended to provide data to support the safety and effectiveness of new devices for obesity. Some of these issues include the choice of the appropriate study end-points, duration of the study, the need for sham comparators, and patient preference. Ideas are then proposed for future studies to aid in getting new devices to market.","PeriodicalId":10446,"journal":{"name":"Clinical Research and Regulatory Affairs","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2015-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Considerations for clinical trial design with obesity-related devices\",\"authors\":\"Herbert Lerner, Martha W. Betz\",\"doi\":\"10.3109/10601333.2015.983647\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract Diet and exercise as a first line therapy do not appear to adequately address the epidemic of obesity seen worldwide. In the US there have only been two devices legally marketed in the last 10 years intended to treat obesity, with many more under clinical investigation. New drugs have recently been approved and, although they appear to provide some benefit, the use of these is associated with many side-effects and with an uncertain sustained weight loss. Using the benefit–risk paradigm as a basis for future study design, this editorial discusses the significant issues associated with the clinical trials intended to provide data to support the safety and effectiveness of new devices for obesity. Some of these issues include the choice of the appropriate study end-points, duration of the study, the need for sham comparators, and patient preference. Ideas are then proposed for future studies to aid in getting new devices to market.\",\"PeriodicalId\":10446,\"journal\":{\"name\":\"Clinical Research and Regulatory Affairs\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-01-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Research and Regulatory Affairs\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3109/10601333.2015.983647\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Research and Regulatory Affairs","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3109/10601333.2015.983647","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

饮食和运动作为一线治疗似乎不能充分解决肥胖在世界范围内的流行。在美国,在过去的10年里,只有两种用于治疗肥胖的设备合法上市,还有更多的设备正在临床研究中。新的药物最近被批准,虽然它们似乎提供了一些好处,但使用这些药物有许多副作用,并且不确定是否能持续减肥。利用获益-风险范式作为未来研究设计的基础,这篇社论讨论了与临床试验相关的重要问题,旨在提供数据来支持治疗肥胖的新设备的安全性和有效性。其中一些问题包括选择适当的研究终点、研究的持续时间、是否需要假比较器以及患者的偏好。然后为未来的研究提出想法,以帮助将新设备推向市场。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Considerations for clinical trial design with obesity-related devices
Abstract Diet and exercise as a first line therapy do not appear to adequately address the epidemic of obesity seen worldwide. In the US there have only been two devices legally marketed in the last 10 years intended to treat obesity, with many more under clinical investigation. New drugs have recently been approved and, although they appear to provide some benefit, the use of these is associated with many side-effects and with an uncertain sustained weight loss. Using the benefit–risk paradigm as a basis for future study design, this editorial discusses the significant issues associated with the clinical trials intended to provide data to support the safety and effectiveness of new devices for obesity. Some of these issues include the choice of the appropriate study end-points, duration of the study, the need for sham comparators, and patient preference. Ideas are then proposed for future studies to aid in getting new devices to market.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Changes to protocol in the regulation of adverse drug reactions – historical and current European view Policy and regulations in light of the human body as a ‘superorganism’ containing multiple, intertwined symbiotic relationships Community pharmacists’ knowledge and perceptions on risk management plans in the Southern Region of Portugal Increasing the odds of effective drug development: Elevating regulatory affairs professionals to strategic partners Current regulatory challenges and approaches in the registration of herbal drugs in Europe
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1